Simultaneous analysis of four standards of the herbal formula, df-02, of ephedra intermedia and rheum palmatum, using by high performance liquid chromatography-ultraviolet detector (HPLC-UVD)open access
- Authors
- Choi, Seong Yeon; Jeong, Birang; Jang, Hyeon Seok; Lee, Jiho; Kwon, Yong Soo; Yoon, Yoosik; Shin, Soon Shik; Yang, Heejung
- Issue Date
- 2019
- Publisher
- Korean Society of Pharmacognosy
- Keywords
- (+)-Pseudoephedrine; (−)-Ephedrine; Aloe-emodin; Chrysophanol; Ephedra intermedia; HPLC; Rheum palmatum; Validation
- Citation
- Natural Product Sciences, v.25, no.2, pp 111 - 114
- Pages
- 4
- Journal Title
- Natural Product Sciences
- Volume
- 25
- Number
- 2
- Start Page
- 111
- End Page
- 114
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/39402
- DOI
- 10.20307/nps.2019.25.2.111
- ISSN
- 1226-3907
- Abstract
- − The herbal formula, DF-02, consisting of Ephedra intermedia and Rheum palmatum are used for the treatment of the metabolic diseases such as obesity and liver fibrosis in Korean local clinics. We aimed to develop the simultaneous analytical conditions for four standards, (+)-pseudoephedrine (PSEP) and (−)-ephedrine (EP) for E. intermedia, and aloe-emodin (AE) and chrysophanol (CP) for R. palmatum using HPLC-UV techniques. The validated conditions yielded the high precision (relative standard deviation (RSD) < 3.65%) and the recoveries (94 – 106%) using the calibration curves with high linearity (R2> 0.9994). As a result, four standards of DF-02 were simultaneously determined under the developed method, which will be utilized for the quality control or evaluation of DF-02 and many herbal preparations containing E. intermedia and R. palmatum. © 2019, Korean Society of Pharmacognosy. All rights reserved.
- Files in This Item
-
- Appears in
Collections - College of Medicine > College of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/39402)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.